Compositions and methods for organ specific delivery of nucleic acids

Organic compositions to treat HSF1-related diseases

ASYMMETRIC SIRNA INHIBITING EXPRESSION OF PD-1

COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof

SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF FOR CORONAVIRUS DISEASES

TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR THE TREATMENT OF CANCER

MOLECULAR GUIDE SYSTEM PEPTIDES AND USES THEREOF

NUCLEIC ACID DELIVERY ENHANCER

HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

ORAL DELIVERY OF OLIGONUCLEOTIDES

GENE THERAPY TARGETING COCHLEAR CELLS

Nucleus-encoded male sterility through mutation in cytochrome P450 oxidase

Temperature-based transient delivery of nucleic acids and proteins to cells and tissues

siRNA EXPRESSION VECTOR

VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA

TREATMENT OF RENAL CYSTIC DISEASE

REACTIVATING P53 MUTANTS FOR CANCER TREATMENT BY TARGETING PROLIDASE (PEPD)

METHODS OF CANCER TREATMENT BY INHIBITION OF VASCULOGENESIS AND GLI1

COMPOSITIONS AND METHODS FOR LOADING EXTRACELLULAR VESICLES WITH CHEMICAL AND BIOLOGICAL AGENTS/MOLECULES

Dynamic pharmacokinetic-modifying anchors

ANTISENSE COMPOUNDS AND USES THEREOF

COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY

FN3 domain-siRNA conjugates and uses thereof

TREATMENT/PREVENTION OF DISEASE BY LINC COMPLEX INHIBITION

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

THREE-DIMENSIONAL FLOW PATH STRUCTURE BODY AND NANOPARTICLE PRODUCTION METHOD USING SAME

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS

Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

METHOD OF STIMULATING PROLIFERATION OF A CELL

Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof

COMPOSITIONS AND METHODS FOR TREATING CYTOTOXIC T CELL RESISTANT TUMORS

CD5 SPECIFIC T CELL RECEPTOR CELL OR GENE THERAPY

TREATMENT OF MAJOR DEPRESSIVE DISORDER BY LOW DOSE INTERLEUKIN-2

INSECT EXTRACELLULAR VESICLES FOR DELIVERY OF NUCLEIC ACIDS

Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases

NUCLEIC ACID, COMPOSITION AND CONJUGATE COMPRISING THE SAME, PREPARATION METHOD AND USE THEREOF

METHODS AND COMPOSITIONS FOR TYPE 2 DIABETES THERAPY

Enhancing Production of Lentiviral Vectors

PHARMACEUTICAL COMPOSITION CONTAINING HERES EXPRESSION INHIBITOR FOR PREVENTING OR TREATING SQUAMOUS CELL CARCINOMA

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

p63 inactivation for the treatment of heart failure

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

HYBRID NUCLEIC ACID MOLECULES AND THEIR USE

GNAQ targeted dsRNA compositions and methods for inhibiting expression

Oligonucleotide-ligand conjugates and process for their preparation

Enhanced immune cells using dual shRNA and composition including the same

CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

Exosome-Mediated Transfection for Delivery of Nucleic Acids

RNAi insecticide materials and methods

Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression

RNAI CONSTRUCTS FOR INHIBITING SLC30A8 EXPRESSION AND METHODS OF USE THEREOF

SUGAR CHAIN-RELATED GENE AND USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING KETOHEXOKINASE (KHK)

METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES

OLIGONUCLEOTIDES FOR TREATMENT OF ANGIOPOIETIN LIKE 4 (ANGPTL4) RELATED DISEASES

Methods for treating SARS-CoV-2 infection

INHIBITOR AGAINST EXPRESSION OF IMMUNE CHECKPOINT MOLECULE

USE OF REAGENT FOR DOWN-REGULATING CIRCULAR GENE EXPRESSION IN PREPARATION OF DRUGS FOR PREVENTING AND/OR TREATING PULMONARY FIBROSIS AND DRUG THEREOF

TREATMENT OF HR DEFICIENT CANCER

METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR USING A NLRP3 ANTAGONIST

PARTICLES AND COMPOSITIONS COMPRISING THE SAME FOR TRANSFECTION

MELANOGENESIS DETECTION METHOD USING FAM86A

Products and methods for inhibition of expression of dynamin-1 variants

SiRNA, medical compositions, and methods for treating type ii diabetes using the same

VASCULOGENIC FIBROBLASTS

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

INHIBITION OF MTHFD1L FOR USE IN HYPERTROPHIC HEART DISEASE AND HEART FAILURE

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE

HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES

CD71 binding fibronectin type III domains

ANTIBODY-BIOMOLECULE CONJUGATES LINKED THROUGH MULTIFUNCTIONAL MACROMOLECULE AND USES THEREOF

Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

Nucleic acids for inhibiting expression of TMPRSS6 and iron chelators

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

SMALL INTERFERING RNA (siRNA) FOR INHIBITING THE EXPRESSION OF MINI-CHROMOSOME MAINTENANCE 7 (MCM7) GENE, AND COMPOSITION AND USE THEREOF

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors

Pharmaceutical composition for treatment and prevention of chronic disease

BIO-PRODUCTION OF LENTIVIRAL VECTORS

IMMUNE CELLS EXPRESSING RECEPTOR SPECIFIC TO CLASS I MHC MOLECULE AND INTERFERING RNA FOR BETA2 MICROGLOBULIN GENE

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

Extended dicer substrate agents and methods for the specific inhibition of gene expression

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

Methods and Compositions for Selecting siRNA of Improved Functionality

Gene-regulating compositions and methods for improved immunotherapy

CD52-DEFICIENT CELLS FOR ADOPTIVE CELL THERAPY

A PHARMACEUTICAL COMPOSITION OF S1PR MODULATORS

Using fatty acid synthase inhibitors to treat fibrosis

PLANT VIRAL NUCLEIC ACID DELIVERY PARTICLES AND USES THEREOF

RECONSTRUCTING HUMAN EARLY EMBRYOGENESIS IN VITRO WITH PLURIPOTENT STEM CELLS

ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT

COMPOSITION FOR PREVENTING OR TREATING CANCER

Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors

USES OF SYNTHETIC LETHAL PARTNERS FOR TREATMENT OF CANCER

PROCESS OF DELIVERING SMALL RNAS TO SPERM

DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM

RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF

PROCESS FOR FORMULATING AN ANIONIC AGENT

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAI

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi

SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS OF TREATING CANCER WITH AN INHIBITOR OF ZNF827

METHODS AND COMPOSITIONS FOR MICROBIAL DELIVERY OF DOUBLE STRANDED RNA

SIRNA SEQUENCES TARGETING THE EXPRESSION OF HUMAN GENES JAK1 OR JAK3 FOR A THERAPEUTIC USE

APPLICATION OF COMBINED INHIBITION OF LNCRNA SAMMSON AND BRAF KINASE IN DELAYING ADAPTIVE DRUG-RESISTANCE OF MELANOMA

GALNAC CLUSTER PHOSPHORAMIDITE AND TARGETED THERAPEUTIC NUCLEOSIDES

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

METHODS OF TREATING CANCERS CONTAINING FUSION GENES

NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS

Suppression of pathological angiogenesis by inhibition of NR2F6

COMPOSITIONS AND METHODS FOR INHIBITING PCSK9

A Method Of Promoting Survival And/Or Function Of A Motor Neuron And Related Agents, Uses And Methods

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

USE OF MÜLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING CANCER

Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro

Defined multi-conjugates oligonucleotides

Modified RNA agents with reduced off-target effect

Nucleic acids for inhibiting expression of LPA in a cell

Products and compositions

COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION

Muscle targeting complexes and uses thereof for treating dystrophinopathies

CONJUGATES AND METHODS FOR TREATING ACROMEGALY

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

2'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS

High performance multi-input microRNA sensors and uses thereof

CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCER

METHODS OF INDUCING INSULIN PRODUCTION

Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

LONG NON-CODING RNA IN CANCER

VH4 antibodies and compositions comprising the same

METHODS OF TREATING P53 MUTANT CANCERS USING OGDH INHIBITORS

METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

Methods And Compositions For Enhancing AAV-Mediated Homologous Recombination Using Ribonucleotide Reductase Inhibitors

Methods and compositions for targeting RNA polymerases and non-coding RNA biogenesis to specific loci

TARGETING SLC38A2 IN PANCREATIC CANCER

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

Oligonucleotide interference treatments of prostate cancer

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION

USE OF RAB7 GTPASE (RAB7) INHIBITORS IN ENHANCING PERMEABILITY OF THE BLOOD BRAIN BARRIER (BBB)

Striatin interacting protein inhibitor and use thereof in preparation of anti-tumor drug

COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)

T CELL RECEPTORS AND METHODS OF USE THEREOF

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

CONJUGATES OF BILE ACIDS AND THEIR DERIVATIVES FOR ACTIVE MOLECULES DELIVERY

SiRNA structures for high activity and reduced off target

NUCLEIC ACID DRUG TARGETING MURF1

METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES

CANCER TREATMENT USING TARGETED siRNA PHARMACEUTICAL FORMULATIONS TO DOWNREGULATE EXPRESSION OF PRDM14 PROTEIN

COMPOSITIONS AND METHODS OF USING C/EBP ALPHA SARNA

MEDICAL USES, METHODS AND USES

METHODS FOR TREATING OR PREVENTING CONTACT-ACTIVATION PATHWAY-ASSOCIATED DISEASES USING iRNA COMPOSITIONS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12)

HSD17B13 variants and uses thereof

Gene-regulating compositions and methods for improved immunotherapy

BIODEGRADABLE CATIONIC POLYMERS AND USES THEREOF

SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION

OLIGONUCLEOTIDE ANTAGONISTS FOR RNA GUIDED GENOME EDITING

CONTROL OF MAMMALIAN GENE DOSAGE USING CRISPR

Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)

ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF

Methods of Treating Transthyretin (TTR) Mediated Amyloidosis

MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE

TREATMENT AND PREVENTION OF DISEASE MEDIATED BY WWP2

Methods and compositions related to RNA-targeted Rho small GTPase RND3/RhoE therapy

CELLS ENGINEERED FOR OLIGONUCLEOTIDE DELIVERY, AND METHODS FOR MAKING AND USING THEREOF

Compositions and Methods for Reducing Perineural Invasion and Pain

p16INK4a INHIBITOR FOR PREVENTING OR TREATING HUNTINGTON'S DISEASE

EPH2A APTAMER AND USES THEREOF

O-methyl rich fully stabilized oligonucleotides

OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA

PEGylated synthetic KL4 peptide, Compositions and Methods Thereof

TRANSFECTION METHOD

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

SEX-LINKED RNAI INSECTICIDE MATERIALS AND METHODS

Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof

Compositions and Methods for Monitoring, Diagnosis, Detection and Treatment of Cancer

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL

Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene

COMPOSITIONS AND METHODS FOR PROVIDING CHEMOPROTECTIVE EFFECTS

Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

RNAi Inhibition of Alpha-ENaC Expression

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

GALANIN- AND GALANIN RECEPTOR BASED COMPOUNDS FOR THE TREATMENT OF LIVER FIBROSIS

USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS

Carboxypeptidase B2 (CPB2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA

SERPIN FAMILY F MEMBER 2 (SERPINF2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

OLIGONUCLEOTIDES FOR DGAT2 MODULATION

COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR MODULATING EXPRESSION OF DUX4

NUCLEIC ACID MOLECULES ENCODING AN ENGINEERED ANTIGEN RECEPTOR AND AN INHIBITORY NUCLEIC ACID MOLECULE AND METHODS OF USE THEREOF

THERAPEUTIC TARGETS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Compositions and methods for the delivery of nucleic acids

METHODS AND COMPOSITIONS FOR MODULATION OF AN INTERSPECIES GUT BACTERIAL PATHWAY FOR LEVODOPA METABOLISM

METHODS AND COMPOSITIONS FOR TREATING MELANOMA

METHOD FOR INHIBITING INFECTION AND ACTIVATION OF VIRUS

MODULATORS OF TELOMERE DISEASE

METHODS OF TREATING DISEASES ASSOCIATED WITH CELLS EXHIBITING ER STRESS OR WITH NEURAL TISSUE DAMAGE

MEDIATORS OF GENE SILENCING

Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

Gene-regulating compositions and methods for improved immunotherapy

METHOD OF PRODUCING MICROBIAL OIL CONTAINING FATTY ACIDS OBTAINED FROM STRAMENOPILE

Method of treating aging-associated cognitive impairment by reducing CCR3

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERS

DUAL TARGETING siRNA AGENTS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

Bruton's Tyrosine Kinase as Anti-Cancer Drug Target

Treatment of amyotrophic lateral sclerosis (ALS)

ORAL DELIVERY OF OLIGONUCLEOTIDES

Nanoparticle to target cancer

RNAi agents for inhibiting expression of HIF-2 alpha (), compositions thereof, and methods of use

COMPOSITIONS AND METHODS FOR RAPID AND DYNAMIC FLUX CONTROL USING SYNTHETIC METABOLIC VALVES

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Agent for use in the treatment of glioma

HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RETROVIRAL VECTOR HAVING IMMUNE-STIMULATING ACTIVITY

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL

RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)

COMPOSITIONS AND METHODS FOR TREATING RAS-MUTANT CANCERS

Haploid induction compositions and methods for use therefor

IMPROVEMENTS RELATING TO CELL TRANSFECTION

ARGONAUTE PROTEINS FROM PROKARYOTES AND APPLICATIONS THEREOF

METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1

Therapeutic Targets for Oncogenic KRAS-Dependent Cancers

CELL-PENETRATING PEPTIDES

INHIBITION OF HISTONE METHYL TRANSFERASES TO TREAT CANCER

Treatment and diagnosis of inflammatory disorders

HIPK INHIBITORS AND METHODS OF USE THEREOF

Modified short interfering nucleic acid (siNA) molecules and uses thereof

ENDOSOMAL CLEAVABLE LINKERS

Antisense Oligonucleotides Targeting ATXN3

ENGINEERED EXOSOMES FOR TARGETED DELIVERY

DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES WITH SHORTENED SENSE STRANDS

HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID

AIM2 INHIBITORS AND USES THEREOF

Method for diagnosis of Alzheimer's disease using microrna

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM

RNAI MOLECULE

CONTROL OF INSECT PESTS USING RNA MOLECULES

IN VIVO DELIVERY OF OLIGONUCLEOTIDES

Nucleic acids for inhibiting expression of LPA in a cell

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

T CELL RECEPTORS AND METHODS OF USE THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND DISORDERS ASSOCIATED WITH THE SPINAL CORD

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Modulatory polynucleotides

Extended dicer substrate agents and methods for the specific inhibition of gene expression

COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION

POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

Mammalian somatic cell with modified RNA encoding reprogramming factors

BIFUNCTIONAL VECTORS ALLOWING BCL11A SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF B-HEMOGLOBINOPATHIES

SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT

Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases

PROCESS CONTROL IN CELL BASED ASSAYS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRAS ASSOCIATED DISEASES OR DISORDERS

NOVEL NUCLEIC ACID MOLECULES AND THEIR USE IN THERAPY

CHMP2A as a Regulator of Natural Killer Cell-Mediated Activity

T CELL RECEPTORS AND METHODS OF USE THEREOF

Therapeutic targets for facioscapulohumeral muscular dystrophy

RSK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES

FRAGILE X MENTAL RETARDATION PROTEIN INTERFERING OLIGONUCLEOTIDES AND METHODS OF USING SAME

siRNA/Nanoparticle Formulations for Treatment of Middle-East Respiratory Syndrome Coronaviral Infection

CTLA-4 aptamer conjugates

Methods and compositions for increased double stranded RNA production

Muscle targeting complexes and uses thereof for treating dystrophinopathies

siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer

TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS

Compositions for treating heart disease by inhibiting the action of mAKAP-β

PREVENTION OR TREATMENT OF FIBROTIC DISEASE

TARGETING SENESCENT CELLS

DIAGNOSIS AND TREATMENT OF MEDULLOBLASTOMA

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL

CORE MASTER REGULATORS OF GLIOBLASTOMA STEM CELLS

NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1

Compositions and methods of treating muscle atrophy and myotonic dystrophy

TARGETING MICRORNAS TO OVERCOME DRUG TOLERANCE AND RESISTANCE

MODULATION OF CILIOGENESIS